The EPS projection of Cigna Corporation (NYSE:CI) for quarter ended 2016-09-30 is $2.45. Last week, the projection for EPS was $2.45 against target of $2.45, a month earlier. While 2-months ago, this projection was $2.45 versus forecast of $2.45a quarter months earlier, posting a deviation of 0%.
Cigna Corporation (NYSE:CI) posted that 18 days earlier, the share price was revised 4 times on upside. In addition, negative revisions were 2.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 1 times. In last one-month and two month the positive revisions were 1 and 1. While in last 120 and 90 days, positive revisions were 7, and 7, correspondingly.
The per-share earnings downgrade for Cigna Corporation (NYSE:CI) in the preceding 30 and 120 were 0 and 0. While in 60 and 90 days were 0, and 0, in that order.
Cigna Corporation (NYSE:CI) EPS target was $2.45 for the quarter closed 1. It was based on 10 calls. As on 2016-05-06 the EPS was $2.32. The change was $0.15, posting a deviation of 6.91%. The price projections gave a standard deviation of 0.04.
Quarterly Sales Estimates
Cigna Corporation (NYSE:CI) sales prediction for the fiscal 2017 stands at $10385.726 and the median estimate is at $10811. Almost 5 analysts gave sales target.
Among this, the highest sales estimate is $10897 while the lowest target is $9244 showing standard deviation of 712.418%.
As many as 5 analysts have positive sales targets revision while 5 reduced sales estimates, posting a deviation of 0%.
Last month, 5 experts have positive sales number revision. Also, 5 research groups lowered the sales projections, posting a deviation of 3.113%.
A quarter ago, 5 hiked sales target and 5 reduced sales forecast, posting a deviation of 3.937%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...